[NDRA] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[NDRA] ENDRA Life Sciences Inc.
Announcement Date
14-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -16.19%
YoY- 2.69%
Quarter Report
NDRA's Result
NDRA's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 0 0 0 0 6 0 0 -
PBT -2,858 -2,269 -3,323 -2,749 -2,825 -742 -379 40.01%
Tax 2,858,199,145 121 235 0 0 381 6 2690.38%
NP -2,858,202,003 -2,269 -3,323 -2,749 -2,825 -742 -379 1298.68%
Tax Rate - - - - - - - -
Total Cost 2,858,202,003 2,269 3,323 2,749 2,831 742 379 1298.68%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 -45,761.31 0.00 0.00 -
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -1,327,722.12 -1.20 -5.77 -7.41 -14.40 -3.80 -1.94 837.79%
EPS Diluted -1,327,722.12 -1.20 -5.77 -7.41 -14.40 -3.80 -1.94 837.79%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.